Anticoagulant
Pregnancy: X — teratogenic in first trimester (warfarin embryopathy). Use LMWH throughout.
Warfarin
Brand names: Coumadin, Marevan
Adult dose
Dose: Individualised — typically 1–10mg OD (INR-guided)
Route: Oral
Frequency: Once daily (at same time each day)
Loading: 10mg OD day 1 (if not elderly/frail/malnourished), then 10mg day 2, then dose-adjust by INR. Alternative: Fennerty loading protocol (10mg, 10mg, 5mg, 5mg then guide by INR). Typical maintenance 3–5mg OD but highly variable.
Dose adjustments
Renal
Use with caution in severe CKD — increased bleeding risk. Frequent INR monitoring required.
Hepatic
Use with extreme caution in hepatic impairment — reduced clotting factor synthesis, unpredictable INR response.
Clinical pearls
- INR targets: AF/VTE prevention: 2–3. Mechanical prosthetic heart valves: 2.5–3.5 (mitral) or 2–3 (aortic).
- Reversal for bleeding: Vitamin K 1–5mg IV or oral; if life-threatening — 4-factor PCC (Beriplex, Octaplex) 25–50 units/kg IV + vitamin K 5–10mg IV. Do NOT wait for FFP effect in emergency.
- Sick day rules for patients: check INR if unwell, vomiting, starting antibiotics, or new medications.
- Consider switching to DOAC (apixaban, rivaroxaban) for non-valvular AF — equivalent efficacy, safer profile, no monitoring. DOACs contraindicated in mechanical valves and antiphospholipid syndrome.
Contraindications
- Active major bleeding
- First trimester of pregnancy (Warfarin embryopathy risk) and near term
- Peptic ulcer disease with high bleeding risk (relative)
- Poorly controlled hypertension (SBP >180 mmHg — bleeding risk)
Side effects
- Bleeding (major — intracranial, GI, retroperitoneal)
- Skin necrosis (rare — first days of treatment, protein C deficiency risk)
- Purple toe syndrome (rare — cholesterol microemboli)
- Alopecia (reversible)
- Teratogenicity (first trimester and near term)
Interactions
- Many interactions — check every new drug for effect on INR
- Amiodarone: markedly increases INR — reduce warfarin dose 30–50%
- Antibiotics (metronidazole, ciprofloxacin): increase INR via gut flora reduction / CYP inhibition
- NSAIDs: additive bleeding risk (GI and COX inhibition on platelet function)
- St John's Wort: reduces INR — enzyme induction
- Cranberry juice: increases INR
Monitoring
- INR — daily until stable
- then weekly
- then monthly (when stable). Monitor more frequently with illness
- new drugs.
Reference: NICE NG196 AF; NICE BNF 84; BNF Warfarin monograph. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Warfarin Dose Adjustment Calculator · Anticoagulation
- HAS-BLED Score · Bleeding Risk
- CHADS₂ Score for AF Stroke Risk · Stroke Risk
- HEMORR₂HAGES Bleeding Risk Score · Prognosis
- ATRIA Bleeding Risk Score · Anticoagulation
- DOAC Score for Selecting Direct Oral Anticoagulant in Non-Valvular AF · Anticoagulation
Drugs
Pathways
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines